München
26.06.26 | 08:12
0,088 Euro
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | OPTHEA LIMITED: Change of Director's Interest Notice - JL | - | ASX | ||
| Do | OPTHEA LIMITED: Notification regarding unquoted securities - OPT | - | ASX | ||
| Mi | OPTHEA LIMITED: Becoming a substantial holder | - | ASX | ||
| Mo | OPTHEA LIMITED: Ceasing to be a substantial holder | - | ASX | ||
| 19.06. | OPTHEA LIMITED: Change of Director's Interest Notice - KC & LG | - | ASX | ||
| 18.06. | Dr Boreham's Crucible: Opthea seeks a second act with rare lung disease program | 1 | Stockhead | ||
| OPTHEA LIMITED ADR Aktie jetzt für 0€ handeln | |||||
| 18.06. | OPTHEA LIMITED: Ceasing to be a substantial holder | - | ASX | ||
| 17.06. | OPTHEA LIMITED: Ceasing to be a substantial holder | - | ASX | ||
| 16.06. | OPTHEA LIMITED: Change in substantial holding | - | ASX | ||
| 12.06. | OPTHEA LIMITED: Change in substantial holding | - | ASX | ||
| 12.06. | OPTHEA LIMITED: Revised Webinar Details and Investor Presentation | - | ASX | ||
| 11.06. | OPTHEA LIMITED: Becoming a substantial holder | - | ASX | ||
| 10.06. | OPTHEA LIMITED: Change in substantial holding | - | ASX | ||
| 09.06. | OPTHEA LIMITED: Change in substantial holding | - | ASX | ||
| 09.06. | OPTHEA LIMITED: Notice of Market Update | - | ASX | ||
| 05.06. | OPTHEA LIMITED: Change in substantial holding | 1 | ASX | ||
| 05.06. | HotCopper Highlights Wk 23: DXN jumps +600%; NST read the riot act, Opthea, 14D & more | 1 | The Market Online Australia | ||
| 04.06. | Why IperionX, Northern Star, Opthea, and Superloop shares are tumbling today | 28 | The Motley Fool Australia | ||
| 03.06. | Wednesday's HotCopper trends: Opthea, Northern Star, Dreadnought, and other daily topics | 21 | The Market Online Australia | ||
| 03.06. | Lunch Wrap: Tech trade cools off while Opthea plunges | 3 | Stockhead |
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PALATIN TECHNOLOGIES | 11,440 | 0,00 % | Palatin Technologies, Inc.: Palatin to Begin Trading on Nasdaq Stock Exchange | PRINCETON, N.J., May 18, 2026 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company focused on the discovery and development... ► Artikel lesen | |
| COSCIENS BIOPHARMA | 1,750 | +5,42 % | COSCIENS Biopharma Inc. Announces Details of Share Capital Amendment | TORONTO, ONTARIO, June 22, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) ("COSCIENS" or the "Company") announced the next steps in connection with changes to the Company's... ► Artikel lesen | |
| HALOZYME THERAPEUTICS | 66,06 | +0,33 % | Halozyme Therapeutics, Inc.: Halozyme Confirms It Projects Zero to Minimal Impact to Royalty Revenue Through At Least 2035 Based on Newly Released Draft Medicare Drug Price Negotiation Program Proposed Rule for IPAY 2029 | SAN DIEGO, June 15, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or the "Company") today confirmed that the Company expects zero... ► Artikel lesen | |
| ABCELLERA BIOLOGICS | 6,400 | -1,23 % | ABCELLERA BIOLG (ABCL) Surges 7.1%: Is This an Indication of Further Gains? | ||
| GLOW LIFETECH | 0,020 | +14,71 % | Glow Lifetech Corp.: Glow Lifetech Achieves Warrant-Free Capital Structure Following Elimination of 70 Million Warrants and 20% Reduction in Fully Diluted Shares | Toronto, Ontario--(Newsfile Corp. - June 2, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce that all of its outstanding 8,900,000... ► Artikel lesen | |
| BIO-RAD LABORATORIES | 261,60 | 0,00 % | ROUNDUP/'WSJ': US-Investor Elliot steigt bei Sartorius-Großaktionär Bio-Rad ein | NEW YORK (dpa-AFX) - Der US-Investor Elliott hat laut einem Medienbericht eine beachtliche Beteiligung an dem Sartorius-Großaktionär Bio-Rad Laboratories aufgebaut. Der aktivistische Investor wolle... ► Artikel lesen | |
| AVID BIOSERVICES | - | - | Avid Bioservices Appoints Maria Ebro Andreasen as Chief People Officer to Fuel Continued Growth and Talent Strategy | Company expands team, university partnerships, and internship programs to build long-term biologics talent pipeline.TUSTIN, Calif., May 18, 2026 /PRNewswire/ -- Avid Bioservices, a leading... ► Artikel lesen | |
| BIOLINERX | 3,260 | +19,85 % | BioLineRx Ltd.: BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update | - Announced first patient dosed in Phase 1/2a clinical trial of GLIX1 for treatment of glioblastoma (GBM) -
- Announced new GLIX1 data demonstrating potent anti-tumor... ► Artikel lesen | |
| WHITEHAWK THERAPEUTICS | 3,620 | 0,00 % | B.Riley initiates Whitehawk Therapeutics stock rating at Buy on ADC portfolio | ||
| MINERVA NEUROSCIENCES | 3,502 | -5,50 % | Minerva Neurosciences, Inc: Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs | Distinguished panel of experts in psychiatry and neuroscience appointed to guide Phase 3 confirmatory trial of roluperidone and broader R&D strategyBURLINGTON, Mass., June 01, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| PARATEK PHARMACEUTICALS | - | - | Paratek Pharmaceuticals: $1.3 Billion Financing Supports Radius Health Combination To Build Specialty Pharma Platform | ||
| OVID THERAPEUTICS | 2,220 | +3,74 % | Ovid Therapeutics Inc.: Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors | NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to pioneering better, gentler medicines for brain disorders with significant... ► Artikel lesen | |
| COCRYSTAL | 0,890 | -0,56 % | Cocrystal Pharma, Inc.: Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer | BOTHELL, Wash., June 03, 2026 (GLOBE NEWSWIRE) -- Cocrystal Pharma Inc. (Nasdaq: COCP) ("Cocrystal" or the "Company"), a clinical-stage biotechnology company developing novel therapeutics to meet... ► Artikel lesen | |
| GEOVAX LABS | 1,310 | -0,76 % | EQS-News: GeoVax, Inc.: GeoVax Highlights Strategic Implications of Recent Gedeptin(R) Findings for Checkpoint-Resistant Cancers | EQS-News: GeoVax, Inc.
/ Key word(s): Financial
GeoVax Highlights Strategic Implications of Recent Gedeptin(R) Findings for Checkpoint-Resistant Cancers 17.06.2026 / 15:03 CET/CEST
The... ► Artikel lesen | |
| PRECISION BIOSCIENCES | 6,630 | +2,95 % | Precision BioSciences, Inc.: Precision BioSciences Announces Late-Breaking Poster Presentation for PBGENE-HBV at European Association for the Study of the Liver Congress 2026 | Late-breaking poster presentation to highlight new biopsy data demonstrating elimination and inactivation of cccDNA from the ongoing Phase 1 ELIMINATE-B trial in chronic hepatitis B
Precision... ► Artikel lesen |
OPTHEA LIMITED ADR gehört der Branche Biotechnologie an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,088 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu OPTHEA LIMITED ADR finden Sie auf Wallstreet Online.